Minerva Neurosciences (NERV) Misses Q4 EPS by 3c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
• Pulmatrix (PULM) Reports Q2 Loss of $0.29